Vesedaganat: nyitott vizsgálatok itt: Franciaország
57 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.
3. fázisToborozTrial-stage medicine
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Angers, Bordeaux Cedex, Brest, Caen Cedex 5, Clermont Ferrand Cedex1, Lille, Marseille, Montpellier Cedex 5, Paris, Poitiers, Reims, Rennes Cedex, Saint-Herblain Cedex, Strasbourg Cedex 2, Toulouse Cedex 9, Villejuif
- Age
- 18 év and over
- People
- 720 worldwide
- Run by
- Arcus Biosciences, Inc.
See details and how to joinNCT07011719EU 2024-515023-11-00Regiszter frissítve: 2026-11-02
3. fázisToborozTrial-stage medicine
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
- Where
- Angers, Dijon, Le Mans, Marseille, Nice Cedex 2, Paris, Saint-Priest-en-Jarez, Toulouse Cedex 9, Villejuif
- Age
- 18 év and over
- People
- 758 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07489495EU 2024-516993-31-00Regiszter frissítve: 2026-10-29
1/2. fázisToborozTrial-stage medicine
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
- Where
- Rennes Cedex, Strasbourg Cedex 2, Toulouse Cedex 9, Vandouvre Les Nancy, Villejuif
- Age
- 18 év to 120 év
- People
- 140 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07049926EU 2024-516437-12-00Regiszter frissítve: 2026-10-27
1/2. fázisToborozTrial-stage medicine
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Where
- Bordeaux Cedex, Lille, Villejuif
- Age
- 18 év and over
- People
- 474 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07293351EU 2026-527163-15-00Regiszter frissítve: 2026-10-23
1. fázisToborozTrial-stage medicine
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Where
- Lyon, Paris, Toulouse Cedex 9
- Age
- 18 év and over
- People
- 300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06026410EU 2024-513285-19-00Regiszter frissítve: 2026-10-14
No phaseToborozResearch participation
Post-immunotherapy Nephrectomy for Metastatic Kidney Cancer After Complete or Major Response to Systemic Therapy
- Where
- Marseille
- Age
- 18 év and over
- People
- 60
- Run by
- Institut Paoli-Calmettes
See details and how to joinNCT06882486Regiszter frissítve: 2026-10-14
No phaseToborozResearch participation
Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations
- Where
- Boulogne-Billancourt, Paris
- Age
- 18 év and over
- People
- 100
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07739121Regiszter frissítve: 2026-10-07
3. fázisToborozResearch participation
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Angers, Limoges Cedex I, Strasbourg Cedex 2, Toulouse Cedex 9, Villejuif
- Age
- 18 év and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00EU 2025-524160-38-00Regiszter frissítve: 2026-10-01
1. fázisToborozTrial-stage medicine
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Besancon Cedex, Bordeaux, Caen Cedex 5, Clermont Ferrand Cedex1, Marseille, Nice Cedex 2, Paris, Rennes Cedex, Saint-Herblain, Strasbourg Cedex 2, Vandoeuvre Les Nancy_ Cedex, Villejuif
- Age
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483EU 2023-510061-10-00Regiszter frissítve: 2026-10-01
1/2. fázisToborozTrial-stage medicine
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
- Where
- Villejuif
- Age
- 18 év and over
- People
- 75 worldwide
- Run by
- Oncorena AB
See details and how to joinNCT05287945Regiszter frissítve: 2026-10-01
1. fázisToborzás még nem indultTrial-stage medicine
A Study to Assess the Safety and Tolerability of BMS-986527 in Participants With Clear Cell Renal Cell Carcinoma (ccRCC)
- Where
- Marseille, Villejuif
- Age
- 18 év and over
- People
- 112 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07848295Regiszter frissítve: 2026-09-30
3. fázisToborozResearch participation
CARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
- Where
- 71100, Ajaccio, Angers, Avignon, Bayonne, Besançon, Bordeaux Cedex, Boujan-sur-Libron, Boulogne-sur-Mer, Brest, Caen Cedex 5, Chalon Sur Saone Cedex, Chambéry, Clermont-Ferrand, Colmar Cedex, Compiègne, Creteil Cedex, Dax, Dijon, Epagny Metz-Tessy, Grenoble Cedex 9, La Roche Sur Yon Cedex 9, Lille, Limoges Cedex 1, Limoges Cedex I, Lyon, Marseille, Martinique, Mont-De-Marsan Cedex, Montpellier Cedex 5, Nice Cedex 2, Nimes Cedex 9, ORLEANS, Paris, Paris Cedex 20, Pau Cedex, Pierre-Bénite, Plérin, Poitiers, Reims, Rennes Cedex, Saint-Denis, Saint-Etienne, Saint-Mande, Saint-Priest-en-Jarez, St Herblain, St Nazaire, Strasbourg, Suresnes, Toulouse, Tours Cedex 9, Vandouvre Les Nancy, Villefranche-sur-Saône, Villejuif
- Age
- 18 év and over
- People
- 1373 worldwide
- Run by
- Institut Gustave Roussy
See details and how to join2023-503317-29-00EU 2023-503317-29-00Regiszter frissítve: 2026-09-28
1. fázisToborzás még nem indultTrial-stage medicine
Phase I Study Evaluating 161Tb-PSMA Therapy in Adult Patients With Metastatic Clear Cell Renal Cell Carcinoma
- Where
- Lyon
- Age
- 18 év and over
- People
- 26
- Run by
- Centre Leon Berard
See details and how to joinNCT07828249EU 2026-525526-38-00Regiszter frissítve: 2026-09-18
1/2. fázisToborozResearch participation
Kidney cancer
- Where
- Villejuif
- Age
- 18 év and over
- People
- 105 worldwide
- Run by
- Oncorena AB
See details and how to join2023-505605-16-00EU 2023-505605-16-00Regiszter frissítve: 2026-09-15
No phaseToborozResearch participation
Development of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney, Bladder, and Prostate Cancers)
- Where
- Strasbourg
- Age
- 18 év and over
- People
- 100
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT07820566Regiszter frissítve: 2026-09-15
No phaseToborozResearch participation
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Besançon, Levallois-Perret, Marseille, Neuilly, Paris
- Age
- 18 év and over
- People
- 2285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444Regiszter frissítve: 2026-09-14
4. fázisToborzás még nem indultResearch participation
Randomized study evaluating the impact of an innovative and cooperative pathway integrating oncogeriatric, pharmaceutical and pharmacological follow-up in elderly patients (>70 years old) presenting with cancer and treated with oral therapy_POG
- Where
- Bron, Caluire-et-Cuire, Chevilly-Larue, Dijon, Lille Cedex, Lyon Cedex 04, Marseille, Paris, PARIS, Paris Cedex 20, Pierre-Bénite, Rennes Cedex, Saint-Cloud, Strasbourg Cedex 2, Toulouse, Villejuif
- Age
- 65 év and over
- People
- 794
- Run by
- Institut Gustave Roussy
See details and how to join2025-523610-83-00EU 2025-523610-83-00Regiszter frissítve: 2026-09-08
4. fázisToborzás még nem indultResearch participation
Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients.
- Where
- Villejuif
- Age
- 70 év and over
- People
- 794
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07802847Regiszter frissítve: 2026-09-03
No phaseToborozResearch participation
Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
- Where
- Créteil, Lyon
- Age
- 18 év and over
- People
- 2000 worldwide
- Run by
- Mark C Burgmans, MD PhD
See details and how to joinNCT07636148Regiszter frissítve: 2026-09-01
1/2. fázisToborozTrial-stage medicine
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
- Where
- Clermont Ferrand Cedex1, Dijon, La Tronche, Lyon, Marseille, Nantes, Pessac, Toulouse Cedex 9, Vandoeuvre Les Nancy
- Age
- 18 év and over
- People
- 270 worldwide
- Run by
- Lumara Bio Oncologics GmbH
See details and how to joinNCT05706129EU 2023-504254-35-00Regiszter frissítve: 2026-08-11
1. fázisToborozTrial-stage medicine
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
- Where
- Bordeaux Cedex, Marseille, Villejuif
- Age
- 18 év and over
- People
- 281 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07195682EU 2025-522543-18-00Regiszter frissítve: 2026-08-11
No phaseToborozResearch participation
Identification and Description of Patients With High-risk Non Metastatic RCC
- Where
- Bordeaux
- Age
- 18 év and over
- People
- 6109
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT07753343Regiszter frissítve: 2026-08-07
1. fázisToborozTrial-stage medicine
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Bordeaux, Villejuif
- Age
- 18 év and over
- People
- 307 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT05433142EU 2024-513619-28-00Regiszter frissítve: 2026-08-03
3. fázisToborozTrial-stage medicine
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
- Where
- Angers, Bayonne, Bordeaux Cedex, Creteil Cedex, Grenoble Cedex 9, La Roche Sur Yon Cedex 9, Limoges Cedex I, Montpellier, Nancy, Pierre-Bénite, Rouen, Suresnes
- Age
- 18 év and over
- People
- 904 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07227402EU 2024-517136-21-00Regiszter frissítve: 2026-08-03
4. fázisToborozTrial-stage medicine
Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma
- Where
- Avignon, Bayeux, Boulogne-sur-Mer, Caen, Caen Cedex 5, Coudekerque-Branche, Creil, Dijon, Epagny Metz-tessy, Lorient, Lyon, Montpellier Cedex 5, Mulhouse, Nice Cedex 2, Poitiers, St Etienne Cedex 2, Suresnes, Tours, Vannes
- Age
- 18 év and over
- People
- 83
- Run by
- Centre Francois Baclesse
See details and how to joinNCT07028125EU 2024-518991-30-00Regiszter frissítve: 2026-07-14
Minden vizsgálat (Vesedaganat) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.